Related Experiment Video
Updated: May 24, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
PDEF downregulates stathmin expression in prostate cancer
Yamini Sabherwal1, Nitin Mahajan, Donald L Helseth
1Department of Molecular Pharmacology and Biological Chemistry, Robert H. Lurie Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
Prostate-derived Ets transcription factor (PDEF) was found to downregulate stathmin (STMN) in prostate cancer cells. This suggests PDEF may inhibit cancer progression by reducing oncogenic STMN expression, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Proteomics
Background:
- Ets proteins are transcription factors regulating cellular processes.
- Prostate-derived Ets transcription factor (PDEF) is found in epithelial tissues like prostate and breast.
- The role of PDEF in cancer development, particularly prostate cancer, requires further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms of prostate cancer progression.
- To identify proteins differentially expressed in prostate cancer cells with or without PDEF overexpression.
- To understand the functional relationship between PDEF and identified proteins in cancer progression.
Main Methods:
- Utilized iTRAQ labeling and mass spectrometry (MS) for quantitative proteomic analysis.
- Overexpressed PDEF in PC3 human prostate cancer cells using a tetracycline-inducible (Tet-On) system.
- Performed in vitro functional assays to assess the impact of stathmin (STMN) re-expression on PDEF-mediated effects.
Main Results:
- Identified numerous differentially expressed proteins involved in various cellular processes.
- Found stathmin (STMN), a microtubule-destabilizing protein, to be significantly downregulated by PDEF.
- Demonstrated that STMN re-expression reversed the anti-tumorigenic effects of PDEF on cell proliferation, colony formation, and migration in PC3 and CWR22rv1 cells.
Conclusions:
- PDEF downregulates STMN expression in prostate cancer cells.
- PDEF may inhibit prostate cancer progression by transcriptionally downregulating oncogenic STMN.
- Further analysis of differentially expressed proteins can enhance understanding of cancer progression and aid therapeutic development.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs
MicroRNAs
The JAK-STAT Signaling Pathway
Negative Regulator Molecules

